NervGen Pharma Corp. Common stock

NGEN | NASDAQ

$1.43

+$0.06 (+4.38%)

Nov 2, 2026, 10:34 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
PE Ratio	-12.60	-17.06	-15.28	-14.83	-16.36	-16.02
PEG Ratio	-0.18	6.31	2.98	-0.82	5.56	1.25
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	159.85	160.55	-166.81	22.82	12.51	29.48
P/FCF Ratio	-28.50	-24.56	-29.66	-17.25	-25.44	-27.66
P/OCF Ratio	-28.50	-24.56	-29.67	-17.27	-25.45	-27.67
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0.04	-0.10	0.02	n/a	n/a
Quick Ratio	1.16	1.12	0.83	2.27	16.16	8.21
Current Ratio	1.16	1.12	0.83	2.27	16.16	8.21
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	-44.74	n/a	n/a
Return on Equity	-1.27K%	-931.69%	1.11K%	-153.94%	-75.67%	-188.95%
Return on Assets	-190.08%	-123.19%	-169.10%	-86.79%	-71.11%	-167.58%
Return on Invested Capital	-719.57%	-929.53%	981.10%	-167.52%	-76.17%	-189.11%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a